Literature DB >> 15937957

Characterization of medroxyprogesterone and DMBA-induced multilineage mammary tumors by gene expression profiling.

Yuzhi Yin1, Renkui Bai, Robert G Russell, Marcy E Beildeck, Zhihui Xie, Levy Kopelovich, Robert I Glazer.   

Abstract

Mouse mammary tumors arising during medroxyprogesterone-DMBA-mediated mammary carcinogenesis comprised three distinct phenotypes: adenocarcinoma, squamous cell carcinoma, and myoepithelial carcinoma. The molecular signature for each of the three tumor subsets was characterized by gene microarray analysis, and three distinct sets of gene expression profiles were obtained that were corroborated in part by quantitative RT-PCR and immunohistochemistry. These results suggest that this carcinogenesis and gene expression model will be useful for rapidly assessing the histopathological differences arising in mammary carcinogenesis and the effects of tumor promoting or chemoprevention agents. Published 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937957     DOI: 10.1002/mc.20119

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  29 in total

1.  Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGF-beta signaling.

Authors:  Geeta Upadhyay; Yuzhi Yin; Hongyan Yuan; Xin Li; Rik Derynck; Robert I Glazer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Stem cell antigen-1 deficiency enhances the chemopreventive effect of peroxisome proliferator-activated receptorγ activation.

Authors:  Hongyan Yuan; Geeta Upadhyay; Yuzhi Yin; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-28

3.  MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.

Authors:  Liling Wan; Xin Lu; Salina Yuan; Yong Wei; Feng Guo; Minhong Shen; Min Yuan; Rumela Chakrabarti; Yuling Hua; Heath A Smith; Mario Andres Blanco; Marina Chekmareva; Hao Wu; Roderick T Bronson; Bruce G Haffty; Yongna Xing; Yibin Kang
Journal:  Cancer Cell       Date:  2014-06-26       Impact factor: 31.743

4.  The chemopreventive effect of mifepristone on mammary tumorigenesis is associated with an anti-invasive and anti-inflammatory gene signature.

Authors:  Hongyan Yuan; Geeta Upadhyay; Jin Lu; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Prev Res (Phila)       Date:  2012-03-16

5.  Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours.

Authors:  Leander Blaas; Fabio Pucci; Hendrik A Messal; Agneta B Andersson; E Josue Ruiz; Marco Gerling; Iyadh Douagi; Bradley Spencer-Dene; Alexandra Musch; Richard Mitter; Leena Bhaw; Richard Stone; Dorothee Bornhorst; Abdul K Sesay; Jos Jonkers; Gordon Stamp; Ilaria Malanchi; Rune Toftgård; Axel Behrens
Journal:  Nat Cell Biol       Date:  2016-10-31       Impact factor: 28.824

Review 6.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

7.  Inhibition of peroxisome proliferator-activated receptor gamma increases estrogen receptor-dependent tumor specification.

Authors:  Yuzhi Yin; Hongyan Yuan; Xiao Zeng; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

8.  Blocking PPARγ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.

Authors:  Peng-Bo Yang; Pei-Pei Hou; Fu-Yuan Liu; Wen-Bin Hong; Hang-Zi Chen; Xiao-Yu Sun; Peng Li; Yi Zhang; Cui-Yu Ju; Li-Juan Luo; Sheng-Fu Wu; Jia-Xin Zhou; Zhi-Jing Wang; Jian-Ping He; Li Li; Tong-Jin Zhao; Xianming Deng; Tianwei Lin; Qiao Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-21       Impact factor: 11.205

9.  Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways.

Authors:  Xiao-Yang Wang; Yuzhi Yin; Hongyan Yuan; Toshiyuki Sakamaki; Hideyuki Okano; Robert I Glazer
Journal:  Mol Cell Biol       Date:  2008-03-24       Impact factor: 4.272

Review 10.  Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models.

Authors:  Christina N Bennett; Jeffrey E Green
Journal:  Breast Cancer Res       Date:  2008-09-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.